van Bemmel A L, van den Hoofdakker R H
Acta Psychiatr Scand. 1981 May;63(5):453-62. doi: 10.1111/j.1600-0447.1981.tb00695.x.
In a previous study it was shown that in endogenous depression repeated sleep deprivation (SD) during clomipramine treatment resulted in rapid improvement after each SD. However, except after the first night, relapses were observed after all sleep nights following SD (the "recovery nights"). The present pilot study had a therapeutic aim, namely to prevent these relapses. We were interested in whether limitation of sleep during the recovery nights might prevent these relapses and whether different amounts of sleep would have different effects on the course of mood after recovery sleep. Ten endogenously depressed patients were treated with clomipramine and with three SD's. Five patients slept for approximately 2 h, and the other five for about 5 h during the second and third recovery nights. On average, no relapse was shown by these patients and, in fact, there was some additional improvement after these nights, in contrast to the findings in the previous study, where patients were allowed unlimited sleep.
在之前的一项研究中发现,在内源性抑郁症患者中,氯米帕明治疗期间反复进行睡眠剥夺(SD)会使每次SD后病情迅速改善。然而,除了第一个晚上,在SD后的所有睡眠夜晚(“恢复夜晚”)都观察到了病情复发。本初步研究具有治疗目的,即预防这些复发。我们感兴趣的是,在恢复夜晚限制睡眠时间是否可以预防这些复发,以及不同的睡眠时间对恢复睡眠后的情绪变化过程是否会有不同影响。10名内源性抑郁症患者接受氯米帕明治疗并进行了3次SD。5名患者在第二个和第三个恢复夜晚睡眠时间约为2小时,另外5名患者约为5小时。这些患者平均未出现病情复发,实际上,与之前允许患者无限制睡眠的研究结果相比,这些夜晚后病情还有一定程度的额外改善。